Clicky

VENTRIPOINT DIAGNOSTICS(5V7)

Description: Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.


Keywords: Imaging Medical Imaging Oncology Ultrasound Medical Physics Radiology Image Processing Heart Disease Vms Nuclear Medicine Medical Ultrasound Pulmonary Hypertension Medical Ultrasonography Diagnostic Tools Congenital Heart Disease Medical Imaging System 3d Ultrasound A Suite Of Applications Ventripoint Medical System Difficult Imaging

Home Page: ventripoint.com

18 Hook Avenue
Toronto, ON M6P 1T4
Canada
Phone: 416 848 4156


Officers

Name Title
Dr. George Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D. Executive Chairman & Corporate Secretary
Mr. Hugh MacNaught Interim CEO, President & Director
Mr. Jimmy Jeon Chief Financial Officer
Mr. Hirotaka Katagiri CTO & Business Development Division Director
Matt Dobson Marketing Director
Mr. Jim Graba Application Specialist & Chief Trainer
Mr. Bart Hendriks Strategic Partnership Executive

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 6.7326
Price-to-Sales TTM: 133.206
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks